NGEN

NervGen Pharma Corp. - Common stock (NGEN)

About NervGen Pharma Corp. - Common stock (NGEN)

NervGen Pharma Corp. operates as a clinical stage biotech company. It engages in the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.

Details

Daily high
$1.72
Daily low
$1.63
Price at open
$1.68
52 Week High
$6.30
52 Week Low
$1.58
Market cap
138.1M
Dividend yield
-
Volume
378,410
Avg. volume
407,125
P/E ratio
-3.14

NervGen Pharma Corp. - Common stock News

Details

Daily high
$1.72
Daily low
$1.63
Price at open
$1.68
52 Week High
$6.30
52 Week Low
$1.58
Market cap
138.1M
Dividend yield
-
Volume
378,410
Avg. volume
407,125
P/E ratio
-3.14